Unexplained weight loss (UWL), defined as a loss of more than 5% of the total body weight within a span of six months, is a common yet perplexing clinical scenario. It is often a harbinger of serious underlying pathology, necessitating a thorough evaluation. This article aims to provide a comprehensive approach to the evaluation of UWL in clinical practice.
The initial evaluation should focus on a detailed history and physical examination. It is important to ascertain the time frame, amount of weight loss, and associated symptoms. A meticulous review of systems can often hint at the underlying cause. The role of medications, diet, and lifestyle changes should be explored. Physical examination should be comprehensive, focusing on signs of systemic diseases.
Basic laboratory studies should be done, including complete blood count, metabolic panel, liver function tests, thyroid function tests, and tumor markers. Imaging studies, such as CT scans or ultrasound, should be considered based on the clinical suspicion. Endoscopic procedures might be necessary in cases with gastrointestinal symptoms.
If the initial workup is unrevealing, specialized evaluations might be warranted. These could include psychiatric evaluation for eating disorders or depression, rheumatologic workup for connective tissue diseases, or oncologic evaluation for suspected malignancies. The choice of further investigations should be guided by the clinical picture.
Patients with UWL should be closely monitored. If no cause is found despite a thorough evaluation, careful follow-up is essential as some conditions might manifest later. Any new symptoms or signs should prompt a re-evaluation.
Evaluating UWL is a complex task requiring a systematic approach. A meticulous history, physical examination, and judicious use of investigations can often lead to the diagnosis. Close follow-up is crucial in cases where the cause remains elusive. By adopting a comprehensive approach, clinicians can ensure optimal care for patients experiencing UWL.
1.
Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?
2.
The need for more Latinx participants in Alzheimer's trials is urgent.
3.
Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.
4.
Study identifies new approach to protect the brain during radiation therapy
5.
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD
1.
CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review
2.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
3.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
Navigating the Complexities of Ph Negative ALL - Part XV
4.
Lung Cancer: Risk Factors and Prevention
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation